APO RESEARCH · REPORT
Atorvastatin Calcium
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Product & engineering
Understand the product.
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Selected research
Industry Research
Atorvastatin Calcium Industry Research Report 2026
Market perspective
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.
Report Scope
Read the full market overview
This report quantifies the global Atorvastatin Calcium market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Atorvastatin Calcium Market by Company
Pfizer
DSM Sinochem Pharmaceuticals
Ind-Swift
Cadila Pharmaceuticals
Morepen
Sun Pharmaceutical Industries
MSN Laboratories
Dr. Reddy's
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Atorvastatin Calcium Segment by Type
Chemical Synthesis
Biocatalysis
Atorvastatin Calcium Segment by Application
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
Atorvastatin Calcium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atorvastatin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Atorvastatin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atorvastatin Calcium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Atorvastatin Calcium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Atorvastatin Calcium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Atorvastatin Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Synthesis
- Biocatalysis
Applications
- Tablet (Including Dispersible Tablet and General Tablet)
- Capsule
- Others
Companies covered
- Pfizer
- DSM Sinochem Pharmaceuticals
- Ind-Swift
- Cadila Pharmaceuticals
- Morepen
- Sun Pharmaceutical Industries
- MSN Laboratories
- Dr. Reddy's
- Teva Pharmaceutical Industries
- Apotex Pharmachem
- Zheijang Neo-Dankon Pharmaceutical
- Ningbo Menovo Pharmaceuticals Group
- Jialin Pharmaceutical
- Topfond
- Zhejiang Hisun Pharmacutical
- Zhejiang Hongyuan Pharmaceutical
- Hubei Yitai Pharmaceutical
- Jiangsu Hengrui Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Atorvastatin Calcium Market Size (2021-2032)
- 2.2.2 Global Atorvastatin Calcium Sales (2021-2032)
- 2.2.3 Global Atorvastatin Calcium Market Average Price (2021-2032)
- 2.3 Atorvastatin Calcium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chemical Synthesis
- 2.3.3 Biocatalysis
- 2.4 Atorvastatin Calcium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablet (Including Dispersible Tablet and General Tablet)
- 2.4.3 Capsule
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Atorvastatin Calcium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Atorvastatin Calcium Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Atorvastatin Calcium Revenue of Manufacturers (2021-2026)
- 3.4 Global Atorvastatin Calcium Average Price by Manufacturers (2021-2026)
- 3.5 Global Atorvastatin Calcium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Atorvastatin Calcium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Atorvastatin Calcium, Product Type & Application
- 3.8 Global Manufacturers of Atorvastatin Calcium, Established Date
- 3.9 Global Atorvastatin Calcium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer
- 4.1.1 Pfizer Company Information
- 4.1.2 Pfizer Business Overview
- 4.1.3 Pfizer Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Atorvastatin Calcium Product Portfolio
- 4.1.5 Pfizer Recent Developments
- 4.2 DSM Sinochem Pharmaceuticals
- 4.2.1 DSM Sinochem Pharmaceuticals Company Information
- 4.2.2 DSM Sinochem Pharmaceuticals Business Overview
- 4.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product Portfolio
- 4.2.5 DSM Sinochem Pharmaceuticals Recent Developments
- 4.3 Ind-Swift
- 4.3.1 Ind-Swift Company Information
- 4.3.2 Ind-Swift Business Overview
- 4.3.3 Ind-Swift Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ind-Swift Atorvastatin Calcium Product Portfolio
- 4.3.5 Ind-Swift Recent Developments
- 4.4 Cadila Pharmaceuticals
- 4.4.1 Cadila Pharmaceuticals Company Information
- 4.4.2 Cadila Pharmaceuticals Business Overview
- 4.4.3 Cadila Pharmaceuticals Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cadila Pharmaceuticals Atorvastatin Calcium Product Portfolio
- 4.4.5 Cadila Pharmaceuticals Recent Developments
- 4.5 Morepen
- 4.5.1 Morepen Company Information
- 4.5.2 Morepen Business Overview
- 4.5.3 Morepen Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Morepen Atorvastatin Calcium Product Portfolio
- 4.5.5 Morepen Recent Developments
- 4.6 Sun Pharmaceutical Industries
- 4.6.1 Sun Pharmaceutical Industries Company Information
- 4.6.2 Sun Pharmaceutical Industries Business Overview
- 4.6.3 Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sun Pharmaceutical Industries Atorvastatin Calcium Product Portfolio
- 4.6.5 Sun Pharmaceutical Industries Recent Developments
- 4.7 MSN Laboratories
- 4.7.1 MSN Laboratories Company Information
- 4.7.2 MSN Laboratories Business Overview
- 4.7.3 MSN Laboratories Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MSN Laboratories Atorvastatin Calcium Product Portfolio
- 4.7.5 MSN Laboratories Recent Developments
- 4.8 Dr. Reddy's
- 4.8.1 Dr. Reddy's Company Information
- 4.8.2 Dr. Reddy's Business Overview
- 4.8.3 Dr. Reddy's Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dr. Reddy's Atorvastatin Calcium Product Portfolio
- 4.8.5 Dr. Reddy's Recent Developments
- 4.9 Teva Pharmaceutical Industries
- 4.9.1 Teva Pharmaceutical Industries Company Information
- 4.9.2 Teva Pharmaceutical Industries Business Overview
- 4.9.3 Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Teva Pharmaceutical Industries Atorvastatin Calcium Product Portfolio
- 4.9.5 Teva Pharmaceutical Industries Recent Developments
- 4.10 Apotex Pharmachem
- 4.10.1 Apotex Pharmachem Company Information
- 4.10.2 Apotex Pharmachem Business Overview
- 4.10.3 Apotex Pharmachem Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Apotex Pharmachem Atorvastatin Calcium Product Portfolio
- 4.10.5 Apotex Pharmachem Recent Developments
- 4.11 Zheijang Neo-Dankon Pharmaceutical
- 4.11.1 Zheijang Neo-Dankon Pharmaceutical Company Information
- 4.11.2 Zheijang Neo-Dankon Pharmaceutical Business Overview
- 4.11.3 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product Portfolio
- 4.11.5 Zheijang Neo-Dankon Pharmaceutical Recent Developments
- 4.12 Ningbo Menovo Pharmaceuticals Group
- 4.12.1 Ningbo Menovo Pharmaceuticals Group Company Information
- 4.12.2 Ningbo Menovo Pharmaceuticals Group Business Overview
- 4.12.3 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product Portfolio
- 4.12.5 Ningbo Menovo Pharmaceuticals Group Recent Developments
- 4.13 Jialin Pharmaceutical
- 4.13.1 Jialin Pharmaceutical Company Information
- 4.13.2 Jialin Pharmaceutical Business Overview
- 4.13.3 Jialin Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jialin Pharmaceutical Atorvastatin Calcium Product Portfolio
- 4.13.5 Jialin Pharmaceutical Recent Developments
- 4.14 Topfond
- 4.14.1 Topfond Company Information
- 4.14.2 Topfond Business Overview
- 4.14.3 Topfond Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Topfond Atorvastatin Calcium Product Portfolio
- 4.14.5 Topfond Recent Developments
- 4.15 Zhejiang Hisun Pharmacutical
- 4.15.1 Zhejiang Hisun Pharmacutical Company Information
- 4.15.2 Zhejiang Hisun Pharmacutical Business Overview
- 4.15.3 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product Portfolio
- 4.15.5 Zhejiang Hisun Pharmacutical Recent Developments
- 4.16 Zhejiang Hongyuan Pharmaceutical
- 4.16.1 Zhejiang Hongyuan Pharmaceutical Company Information
- 4.16.2 Zhejiang Hongyuan Pharmaceutical Business Overview
- 4.16.3 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product Portfolio
- 4.16.5 Zhejiang Hongyuan Pharmaceutical Recent Developments
- 4.17 Hubei Yitai Pharmaceutical
- 4.17.1 Hubei Yitai Pharmaceutical Company Information
- 4.17.2 Hubei Yitai Pharmaceutical Business Overview
- 4.17.3 Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Hubei Yitai Pharmaceutical Atorvastatin Calcium Product Portfolio
- 4.17.5 Hubei Yitai Pharmaceutical Recent Developments
- 4.18 Jiangsu Hengrui Medicine
- 4.18.1 Jiangsu Hengrui Medicine Company Information
- 4.18.2 Jiangsu Hengrui Medicine Business Overview
- 4.18.3 Jiangsu Hengrui Medicine Atorvastatin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Jiangsu Hengrui Medicine Atorvastatin Calcium Product Portfolio
- 4.18.5 Jiangsu Hengrui Medicine Recent Developments
5 Global Atorvastatin Calcium Market Scenario by Region
- 5.1 Global Atorvastatin Calcium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Atorvastatin Calcium Sales by Region: 2021-2032
- 5.2.1 Global Atorvastatin Calcium Sales by Region: 2021-2026
- 5.2.2 Global Atorvastatin Calcium Sales by Region: 2027-2032
- 5.3 Global Atorvastatin Calcium Revenue by Region: 2021-2032
- 5.3.1 Global Atorvastatin Calcium Revenue by Region: 2021-2026
- 5.3.2 Global Atorvastatin Calcium Revenue by Region: 2027-2032
- 5.4 North America Atorvastatin Calcium Market Facts & Figures by Country
- 5.4.1 North America Atorvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Atorvastatin Calcium Sales by Country (2021-2032)
- 5.4.3 North America Atorvastatin Calcium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Atorvastatin Calcium Market Facts & Figures by Country
- 5.5.1 Europe Atorvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Atorvastatin Calcium Sales by Country (2021-2032)
- 5.5.3 Europe Atorvastatin Calcium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Atorvastatin Calcium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Atorvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Atorvastatin Calcium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Atorvastatin Calcium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Atorvastatin Calcium Market Facts & Figures by Country
- 5.7.1 South America Atorvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Atorvastatin Calcium Sales by Country (2021-2032)
- 5.7.3 South America Atorvastatin Calcium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Atorvastatin Calcium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Atorvastatin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Atorvastatin Calcium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Atorvastatin Calcium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Atorvastatin Calcium Sales by Type (2021-2032)
- 6.1.1 Global Atorvastatin Calcium Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Atorvastatin Calcium Sales Market Share by Type (2021-2032)
- 6.2 Global Atorvastatin Calcium Revenue by Type (2021-2032)
- 6.2.1 Global Atorvastatin Calcium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Atorvastatin Calcium Revenue Market Share by Type (2021-2032)
- 6.3 Global Atorvastatin Calcium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Atorvastatin Calcium Sales by Application (2021-2032)
- 7.1.1 Global Atorvastatin Calcium Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Atorvastatin Calcium Sales Market Share by Application (2021-2032)
- 7.2 Global Atorvastatin Calcium Revenue by Application (2021-2032)
- 7.2.1 Global Atorvastatin Calcium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Atorvastatin Calcium Revenue Market Share by Application (2021-2032)
- 7.3 Global Atorvastatin Calcium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Atorvastatin Calcium Value Chain Analysis
- 8.1.1 Atorvastatin Calcium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Atorvastatin Calcium Production Mode & Process
- 8.2 Atorvastatin Calcium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Atorvastatin Calcium Distributors
- 8.2.3 Atorvastatin Calcium Customers
9 Global Atorvastatin Calcium Analyzing Market Dynamics
- 9.1 Atorvastatin Calcium Industry Trends
- 9.2 Atorvastatin Calcium Industry Drivers
- 9.3 Atorvastatin Calcium Industry Opportunities and Challenges
- 9.4 Atorvastatin Calcium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst